BioTek reMEDys Email Format
Pharmaceutical ManufacturingDelaware, United States51-200 Employees
BioTek reMEDys is a national specialty pharmacy company within the pharmaceutical sector, based in New Castle, Delaware. It provides medications and comprehensive support services to patients, prescribers, payers, and manufacturers. The organization operates on a national scale, delivering specialized therapies and the accompanying support that patients and providers rely on. In 2017, the company launched a Sub Q product, reflecting its efforts to broaden administration options for its therapies. In 2023, BioTek reMEDys and its chief executive officer, Chaitanya Gadde, reached a settlement related to False Claims Act allegations involving kickback payments to patients and physicians. The business maintains a mid-sized workforce to support its operations.